{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:05:51Z","timestamp":1780401951506,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>An objective method to predict individual visual field progression will contribute to realise personalised medication. The purpose of this study was to establish a predictive formula for glaucomatous visual field progression in patients with Primary open-angle glaucoma, mainly including normal tension glaucoma. This study was a large-scale, longitudinal and retrospective study including 498 eyes of 312 patients visiting from June 2009 to May 2015. In this analysis, 191 eyes of 191 patients meeting all eligible criteria were used. A predictive formula to calculate the rate of glaucomatous visual field progression (mean deviation slope) was obtained through multivariate linear regression analysis by adopting \u201cAngle of Retinal Nerve Fibre Layer Defect\u201d at the baseline, \u201cVertical Cup-Disc ratio\u201d at the baseline, \u201cPresence or absence of Disc Haemorrhage\u201d during the follow-up period, and \u201cMean IOP change (%)\u201d during the follow-up period as predictors. Coefficient of determination of the formula was 0.20. The discriminative ability of the formula was evaluated as moderate performance using receiver operating characteristic analysis, and the area under the curve was approximately 0.75 at all cut-off values. Internal validity was confirmed by bootstrapping. The predictive formula established by this type of approach might be useful for personalised medication.<\/jats:p>","DOI":"10.1038\/s41598-017-15267-y","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T20:05:52Z","timestamp":1509653152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma"],"prefix":"10.1038","volume":"7","author":[{"given":"Koji","family":"Nitta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Wajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachie","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ohigashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kurashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Hirukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"15267_CR1","first-page":"887","volume":"82","author":"S Kingman","year":"2004","unstructured":"Kingman, S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ \n                           82, 887\u2013888 (2004).","journal-title":"Bull World Health Organ"},{"key":"15267_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley, H. A. & Broman, A. T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol \n                           90, 262\u2013267 (2006).","journal-title":"Br J Ophthalmol"},{"key":"15267_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/bjo.2005.083733","volume":"90","author":"TY Wong","year":"2006","unstructured":"Wong, T. Y., Loon, S. C. & Saw, S. M. The epidemiology of age related eye diseases in Asia. Br J Ophthalmol \n                           90, 506\u2013511 (2006).","journal-title":"Br J Ophthalmol"},{"key":"15267_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"AGIS investigators. The Advanced Glaucoma Intervention Study (AGIS): 7","year":"2000","unstructured":"AGIS investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol \n                           130, 429\u2013440 (2000).","journal-title":"Am J Ophthalmol"},{"key":"15267_CR5","doi-asserted-by":"crossref","unstructured":"Lichter, P. R. et al. CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 108, 1943\u20131953 (2001).","DOI":"10.1016\/S0161-6420(01)00873-9"},{"key":"15267_CR6","doi-asserted-by":"crossref","unstructured":"Heijl, A. et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 120, 1268\u20131279 (2002).","DOI":"10.1001\/archopht.120.10.1268"},{"key":"15267_CR7","unstructured":"Japan Glaucoma Society. Guidelines for Glaucoma (3rd Edition). Nippon Ganka Gakkai Zasshi. 116, 3\u201346 (2012)."},{"key":"15267_CR8","unstructured":"European Glaucoma Society. Terminology and guidelines for glaucoma (\n                           4th edition\n                           ). 131\u2013138 (Publicomm, 2014)."},{"key":"15267_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ophtha.2015.10.053","volume":"123","author":"BE Prum Jr.","year":"2016","unstructured":"Prum, B. E. Jr. et al. Primary Open-Angle Glaucoma Preferred Practice Pattern Guidelines. Ophthalmology. \n                           123, 41\u2013111 (2016).","journal-title":"Ophthalmology."},{"key":"15267_CR10","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1167\/iovs.11-7900","volume":"53","author":"CG De Moraes","year":"2012","unstructured":"De Moraes, C. G. et al. A Validated Risk Calculator to Assess Risk and Rate of Visual Field Progression in Treated Glaucoma Patients. Invest Ophthalmol Vis Sci \n                           53, 2702\u20132707 (2012).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"15267_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/IJG.0000000000000146","volume":"25","author":"PJ Ernest","year":"2016","unstructured":"Ernest, P. J. et al. Prediction of Glaucomatous Visual Field Progression Using Baseline Clinical Data. J Glaucoma. \n                           25, 228\u2013235 (2016).","journal-title":"J Glaucoma."},{"key":"15267_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/ICU.0b013e3282f3919b","volume":"19","author":"MB Shields","year":"2008","unstructured":"Shields, M. B. Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol \n                           19, 85\u201388 (2008).","journal-title":"Curr Opin Ophthalmol"},{"key":"15267_CR13","first-page":"1641","volume":"111","author":"A Iwase","year":"2004","unstructured":"Iwase, A. et al. Tajimi Study Group, Japan Glaucoma Society. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. \n                           111, 1641\u20131648 (2004).","journal-title":"Ophthalmology."},{"key":"15267_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.survophthal.2013.09.003","volume":"59","author":"HK Cho","year":"2014","unstructured":"Cho, H. K. & Kee, C. Population-based glaucoma prevalence studies in Asians. Surv Ophthalmol. \n                           59, 434\u2013447 (2014).","journal-title":"Surv Ophthalmol."},{"key":"15267_CR15","unstructured":"Fleiss, J. L. The Design and Analysis of Clinical Experiments. 7 (John Wiley & Sons, 1986)."},{"key":"15267_CR16","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/S0161-6420(99)90416-5","volume":"106","author":"P Mitchell","year":"1999","unstructured":"Mitchell, P., Hourihan, F., Sandbach, J. & Wang, J. J. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology. \n                           106, 2010\u20132015 (1999).","journal-title":"Ophthalmology."},{"key":"15267_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00055735-200404000-00008","volume":"15","author":"MC Leske","year":"2004","unstructured":"Leske, M. C., Heijl, A., Hyman, L., Bengtsson, B. & Komaroff, E. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol \n                           15, 102\u2013106 (2004).","journal-title":"Curr Opin Ophthalmol"},{"key":"15267_CR18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.ophtha.2010.10.016","volume":"118","author":"CS Kim","year":"2011","unstructured":"Kim, C. S., Seong, G. J., Lee, N. H. & Song, K. C. Namil Study Group, Korean Glaucoma Society. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. \n                           118, 1024\u20131030 (2011).","journal-title":"Ophthalmology."},{"key":"15267_CR19","doi-asserted-by":"crossref","unstructured":"Sehi, M., Bhardwaj, N., Chung, Y. S. & Greenfield, D. S. Advanced Imaging for Glaucoma Study Group. Evaluation of baseline structural factors for predicting glaucomatous visual-field progression using optical coherence tomography, scanning laser polarimetry and confocal scanning laser ophthalmoscopy. Eye. 26, 1527\u20131535 (2012).","DOI":"10.1038\/eye.2012.203"},{"key":"15267_CR20","first-page":"839","volume":"115","author":"K Nitta","year":"2011","unstructured":"Nitta, K., Sugiyama, K. & Tanahashi, T. Relationship between the frequency of disc hemorrhage and the enlargement of nerve fiber layer defects and the deterioration speed of visual field loss in normal-tension glaucoma with wedge-shaped nerve fiber layer defects. Nippon Ganka Gakkai Zasshi \n                           115, 839\u2013847 (2011).","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"15267_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol \n                           126, 498\u2013505 (1998).","journal-title":"Am J Ophthalmol"},{"key":"15267_CR22","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","volume":"338","author":"DG Altman","year":"2009","unstructured":"Altman, D. G., Vergouwe, Y., Royston, P. & Moons, K. G. Prognosis and prognostic research: validating a prognostic model. BMJ. \n                           338, b605 (2009).","journal-title":"BMJ."},{"key":"15267_CR23","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1126\/science.3287615","volume":"240","author":"JA Swets","year":"1988","unstructured":"Swets, J. A. Measuring the accuracy of diagnostic systems. Science \n                           240, 1285\u20131293 (1988).","journal-title":"Science"},{"key":"15267_CR24","doi-asserted-by":"crossref","unstructured":"Doi, S. A. & Williams, G. M. Methods of Clinical Epidemiology. 69\u201370 (Springer-Verlag, 2013).","DOI":"10.1007\/978-3-642-37131-8"},{"key":"15267_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0161-6420(86)33658-3","volume":"93","author":"T Kitazawa","year":"1986","unstructured":"Kitazawa, T., Shirato, S. & Yamamoto, T. Optic disc hemorrhage in low-tension glaucoma. Ophthalmology. \n                           93, 853\u2013857 (1986).","journal-title":"Ophthalmology."},{"key":"15267_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1442-9071.2010.02482.x","volume":"39","author":"MH Suh","year":"2011","unstructured":"Suh, M. H. & Park, K. H. Period prevalence and incidence of optic disc haemorrhage in normal tension glaucoma and primary open-angle glaucoma. Clin Exp Ophthalmol \n                           39, 513\u2013519 (2011).","journal-title":"Clin Exp Ophthalmol"},{"key":"15267_CR27","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.ophtha.2014.02.007","volume":"121","author":"CG De Moraes","year":"2014","unstructured":"De Moraes, C. G., Furlanetto, R. L., Ritch, R. & Liebmann, J. M. A new index to monitor central visual field progression in glaucoma. Ophthalmology. \n                           121, 1531\u20131538 (2014).","journal-title":"Ophthalmology."},{"key":"15267_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-11-6","volume":"11","author":"MV Boland","year":"2011","unstructured":"Boland, M. V. & Quigley, H. A. Evaluation of a combined index of optic nerve structure and function for glaucoma diagnosis. BMC Ophthalmol. \n                           11, 6, https:\/\/doi.org\/10.1186\/1471-2415-11-6 (2011).","journal-title":"BMC Ophthalmol."},{"key":"15267_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ophtha.2015.10.061","volume":"123","author":"H Yamada","year":"2016","unstructured":"Yamada, H. et al. Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma. Ophthalmology. \n                           123, 542\u2013551 (2016).","journal-title":"Ophthalmology."},{"key":"15267_CR30","unstructured":"European Glaucoma Society. Terminology and guidelines for glaucoma (\n                           3rd edition\n                           ). 95\u201397 (Dogma, 2008)."},{"key":"15267_CR31","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr.","year":"1982","unstructured":"Harrell, F. E. Jr., Califf, R. M., Pryor, D. B., Lee, K. L. & Rosati, R. A. Evaluating the yield of medical tests. JAMA. \n                           247, 2543\u20132546 (1982).","journal-title":"JAMA."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15267-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:16:52Z","timestamp":1671801412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15267-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15267"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15267-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]},"assertion":[{"value":"4 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted under financial support from Santen. K.N., R.W. and G.T. received research grand from Santen. K.N. and K.S. received honoraria for lectures from Santen. K.N., G.T. and K.S. received travel fee from Santen. K.S. received consulting fee from Santen. T.O., N.O., H.K., K.S. and M.H. are employees of Santen.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15048"}}